Prostate cancer detection by TURP after repeated negative saturation biopsy in patients with persistent suspicion of cancer: A case-control study on 75 consecutive patients

Prostate Cancer and Prostatic Diseases

Volumn 13, Issue 1, 2010, Pages 83-86

  Pepe, P ^a   Fraggetta, F ^a   Galia, A ^a   Grasso, G ^a   Aragona, F ^a  

^a CANNIZZARO HOSPITAL   (Italy)

Author keywords

Extended prostate biopsy; Prostate repeated biopsy; PSA; Saturation prostate biopsy; TURP and prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LENGTH OF STAY; LOWER URINARY TRACT SYMPTOM; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATITIS; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; WATCHFUL WAITING;

AGED; BIOPSY; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATISM; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 76949105053     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2009.46     Document Type: Article

References (28)

1. Freedland SJ, Partin AW. Prostate specific antigen: update. Urology 2006; 67: 458-460.
2. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon- Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000; 164: 393-396.
3. Puppo P, Introini C, Calvi P, Naselli A. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 2006; 49: 873-878.
4. Aragona F, Pepe P, Motta M, Saita A, Raciti G, La Rosa P et al. Incidence of prostate cancer in Sicily: results of a multicenter case-findings protocol. Eur Urol 2005; 47: 569-574.
5. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71-75.
6. Norberg M, Egevad L, Holberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of prostate underestimates the presence of cancer. Urology 1997; 50: 562-566.
7. Pepe P, Aragona F. Prostate needle biopsy: 12 vs 18 cores Is it necessary? Urol Int 2005; 74: 19-22.
8. Jones JS, Patel A, Schoefield L, Rabets JC, Zippe CD, Magi-Galluzzi C. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006; 175: 485-488.
9. Pepe P, Aragona F. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 2007; 70: 1131-1135.
10. Yanke BV, Gonen M, Scardino PT, Kattan MW. Validation of nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 2005; 173: 421-424.
11. Scattoni V, Roscigno M, Freschi M, Dehó F, Raber M, Briganti A et al. Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies. Arch Ital Urol Androl 2005; 77: 31-36.
12. Djavan B, Milani S, Remzi M. Prostate biopsy: who, how and when. An update. Can J Urol 2005; 1: 44-48.
13. Campos-Fernandes JL, Bastien L, Nicolaiew M, Robert G, Terry S, Vacherot F et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 2009; 55: 600-609.
14. Philip J, Hanchanale V, Foster CS, Javlè P. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocol. BJU Int 2006; 98: 559-562.
15. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM et al. Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol 2004; 171: 1850-1854.
16. Fleshner N, Klotz L. Role of 'saturation biopsy' in the detection of prostate cancer among difficult diagnostic cases. Urology 2002; 60: 93-97.
17. Walz J, Graefen M, Chun FK, Erbersdobler A, Haese A, Steuber T et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 2006; 50: 498-505.
18. Rabets JC, Jones JS, Patel A, Zippe CD. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol 2004; 172: 94-97.
19. Rodriguez Alonso A, Gonzalez Blanco A, Pita Fernandez S, Suarez Pascual G, Bonelli Martín C, Lorenzo Franco J et al. Prostate cancer diagnosis using 24 cores extended biopsy. Actas Urol Esp 2005; 29: 934-942.
20. Jones JS, Oder M, Zippe CD. Saturation prostate biopsy with periprostatic block can be performed in office. J Urol 2002; 168: 2108-2110.
21. Eskicorapci SY, Guliyev F, Islamoglu E, Eregen A, Ozen H. The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14-core prostate biopsy technique. Int Urol Nephrol 2007; 39: 189-195.
22. Pelzer AE, Bektic J, Berger AP, Halpern EJ, Koppelstätter F, Klauser A et al. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the Tyrol screening project. Eur Urol 2005; 48: 916-921.
23. Miyake H, Kurahashi T, Muramaki M, Yamanak K, Hara I. Significance of routine transition biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies. Int J Urol 2005; 12: 964-968.
24. Radhakrishnan S, Dorkin TJ, Sheikh N, Greene DR. Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies. Prostate Cancer Prostatic Dis 2004; 7: 338-342.
25. Zigeuner R, Schips L, Lipsky K, Auprich M, Salfellner M, Rehak P et al. Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology 2003; 62: 883-887.
26. van Renterghem K, Van Koeveringe G, Achten R, Van Kerrebroeck P. Clinical relevance of transurethral resection of the prostate in 'asymptomatic' patients with an elevated prostate-specific antigen level. Eur Urol 2007; 52: 819-826.
27. Sakai I, Harada K, Kurahashi T, Yamanaka K, Hara I, Miyake H. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones. Int J Urol 2006; 13: 368-372.
28. Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A et al. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur Urol 2008; 54: 118-125.